China Analyst, a financial information website focused on U.S.-listed Chinese stocks, recently released its list of the top 10 pharmaceutical stocks with the highest upside.
AesRx Aims at Two Rare Diseases In Growing Orphan Drug Market
The Newton, Mass.-based biopharmaceutical company is developing a small-molecule drug for sickle cell disease.
